HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cara L Haymaker Selected Research

Chemokine CXCL5

1/2022Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cara L Haymaker Research Topics

Disease

17Neoplasms (Cancer)
02/2024 - 10/2016
6Melanoma (Melanoma, Malignant)
02/2024 - 08/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 01/2020
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
02/2024 - 10/2022
2Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 01/2022
2Malignant Mesothelioma
01/2023 - 01/2022
2Mesothelioma
01/2023 - 01/2023
2Adenocarcinoma
01/2022 - 11/2021
2Lung Neoplasms (Lung Cancer)
01/2020 - 10/2016
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2012 - 04/2010
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2011 - 02/2008
1Lymphoma (Lymphomas)
02/2024
1Neoplasm Metastasis (Metastasis)
12/2023
1Renal Cell Carcinoma (Grawitz Tumor)
10/2023
1Breast Neoplasms (Breast Cancer)
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Neoplasms, Cystic, Mucinous, and Serous
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2021
1Hematologic Neoplasms (Hematological Malignancy)
11/2021
1Urinary Retention
09/2021
1Communicable Diseases (Infectious Diseases)
11/2017
1Infections
11/2017
1Brain Neoplasms (Brain Tumor)
01/2017
1Inflammation (Inflammations)
04/2010

Drug/Important Bio-Agent (IBA)

4RNA (Ribonucleic Acid)IBA
12/2023 - 01/2020
4CytokinesIBA
01/2022 - 01/2020
4AntigensIBA
11/2021 - 08/2012
2PlasticsIBA
02/2024 - 08/2012
2urelumabIBA
02/2024 - 01/2022
2Interleukin-2 (IL2)IBA
02/2024 - 01/2022
2Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2017
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2022
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2021 - 01/2020
2Peptides (Polypeptides)IBA
11/2021 - 10/2011
2TolerogenIBA
10/2011 - 04/2010
1sitravatinibIBA
10/2023
1NivolumabIBA
10/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1Transforming Growth Factor-beta Type II ReceptorIBA
01/2022
1Chemokine CXCL5IBA
01/2022
1Granzymes (Granzyme)IBA
01/2022
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1InterleukinsIBA
01/2022
1durvalumabIBA
01/2022
1trametinibIBA
01/2022
1Long Noncoding RNAIBA
01/2022
1Immune Checkpoint ProteinsIBA
01/2022
1AntibodiesIBA
01/2022
1LigandsIBA
11/2021
1Surface Antigens (Surface Antigen)IBA
11/2021
1Chimeric Antigen ReceptorsIBA
11/2021
1Small Cytoplasmic RNAIBA
11/2021
1Oxygen (Dioxygen)IBA
09/2021
1VaccinesIBA
10/2017
1IpilimumabIBA
10/2016
1pembrolizumabIBA
10/2016
1Myelin-Oligodendrocyte GlycoproteinIBA
10/2011
1Member 3 Group F Nuclear Receptor Subfamily 1IBA
04/2010
1AutoantibodiesIBA
02/2008

Therapy/Procedure

12Therapeutics
02/2024 - 08/2015
6Immunotherapy
01/2022 - 10/2016
2Breast Implants (Breast Implant)
02/2024 - 10/2022
2Neoadjuvant Therapy
01/2023 - 01/2023
1Drug Therapy (Chemotherapy)
02/2024
1Nephrectomy
10/2023
1Pneumonectomy (Lung Volume Reduction)
01/2022
1Precision Medicine
11/2021
1Blood Transfusion (Blood Transfusions)
09/2021
1Chest Tubes (Chest Tube)
09/2021
1Radiotherapy
10/2020
1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2015